<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03885960</url>
  </required_header>
  <id_info>
    <org_study_id>2018/1924</org_study_id>
    <nct_id>NCT03885960</nct_id>
  </id_info>
  <brief_title>Perthes Disease in Norway</brief_title>
  <official_title>A Prospective Nationwide Study of Perthes` Disease in Norway: Functional and Radiographic Outcomes at a Mean Follow-up of Twenty Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sophies Minde Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Calv√©-Legg-Perthes disease (CLP) is a hip disease in children whose femoral head becomes
      completely or partially necrotic. The disease is most common in five-six years of age. The
      femoral head is gradually deformed during the active stages of the disease (5-7 years). By
      healing, the hip joint shape will vary from an approximately normal joint to pronounced
      changes, the hip joint will be irregular. Such a hip joint is available for osteoarthritis.
      The purpose of this study is to map the function of the hip, the patient's quality of life
      and especially the risk factors that affect the outcome of the previous CLP. A nationwide
      prospective study of CLP was conducted between 1996 and 2000. All children with newly
      diagnosed Perthes disease (425) were registered. The current study will follow up all these
      patients with an average follow-up of 20 years. Radiological endpoints are evidence of hip
      osteoarthritis. Patient-reported outcomes (PROMS) should illuminate the function of the hip
      and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hip osteoarthritis</measure>
    <time_frame>an average of 20 years follow-up</time_frame>
    <description>radiographic measurement of weight bearing zone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hip function</measure>
    <time_frame>an average of 20 years follow-up</time_frame>
    <description>PROMS HOOS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hip ROM</measure>
    <time_frame>an average of 20 years follow-up</time_frame>
    <description>functional test of range of motion of the hip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gluteal muscle strength</measure>
    <time_frame>an average of 20 years follow-up</time_frame>
    <description>Trendelenburg test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip strength</measure>
    <time_frame>an average of 20 years follow-up</time_frame>
    <description>single leg hop test - 6 meters</description>
  </secondary_outcome>
  <enrollment type="Anticipated">425</enrollment>
  <condition>Legg Calve Perthes Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients which have been diagnosed with Perthes disease in between 1996 and 2000 in
        Norway were registered and follow at least 5 years after diagnosis. All hospitals
        throughout Norway with orthopaedic service were included in the registration. Our study is
        a 20 years follow-up of the original study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

        - Subject was diagnosed with Perthes disease between 1996 and 2000 in Norway

        Exclusion Criteria:

          -  Death upon follow up

          -  Other skeletal dysplasia

          -  Patient not able to give consent,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Huhnstock, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University Hospital - Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <state>Sognsvannsveien 20</state>
        <zip>0372</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>January 9, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>March 21, 2019</last_update_submitted>
  <last_update_submitted_qc>March 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Stefan Huhnstock</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Hip</keyword>
  <keyword>function</keyword>
  <keyword>quality of life</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>Perthes</keyword>
  <keyword>LCPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Legg-Calve-Perthes Disease</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03885960/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03885960/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

